Interferon γ regulates platelet endothelial cell adhesion molecule 1 expression and neutrophil infiltration into herpes simplex virus-infected mouse corneas

Journal of Experimental Medicine

Volumn 184, Issue 4, 1996, Pages 1435-1447

  Tang, Qizhi ^a   Hendricks, Robert L ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON ANTIBODY; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HERPES SIMPLEX VIRUS 1; INTRAPERITONEAL DRUG ADMINISTRATION; KERATITIS; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIGENS, CD31; CD4-POSITIVE T-LYMPHOCYTES; CORNEA; CORNEAL OPACITY; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FEMALE; HERPESVIRUS 1, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS I; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; KERATITIS, HERPETIC; MICE; MICROCIRCULATION; NEUTROPHILS; UP-REGULATION;

EID: 0029911156     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.4.1435     Document Type: Article

References (54)

1. Hendricks, R.L., P.C. Weber, J.L. Taylor, A. Koumbis, T.M. Tumpey, and J. C. Glorioso. 1991. Endogenously produced interferon alpha protects mice from herpes simplex virus type 1 corneal disease. J. Gen. Virol. 72:1601-1610.
2. Hendricks, R.L., and T.M. Tumpey. 1990. Contribution of virus and immune factors to herpes simplex virus type 1 induced corneal pathology. Invest. Ophthalmol. Vis. Sci. 31: 1929-1939.
3. Niemialtowski, M.G., and B.T. Rouse. 1992. Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis. J. Immunol. 149:3035-3039.
4. Hendricks, R.L., T.M. Tumpey, and A. Finnegan. 1992. IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice. J. Immunol. 149:3023-3028.
5. Tumpey, T.M., V.M. Elner, S.-H. Chen, J.E. Oakes, and R.N. Lausch. 1994. Interleukin-10 treatment can suppress stromal keratitis induced by herpes simplex virus type 1. J. Immunol. 153:2258-2265.
6. Murray, H.W. 1994. Interferon-gamma and host antimicrobial defense: current and future clinical applications. Am. J. Med. 97:459-467.
7. Stout, R.D. 1993. Macrophage activation by T cells: cognate and non-cognate signals. Curr. Opin. Immunol. 5:398-403.
8. Farrar, M.A., and R.D. Schreiber. 1993. The molecular cell biology of interferon-gamma and its receptor. Annu. Rev. Immunol. 11:571-611.
9. Steinbeck, M.J., and J.A. Roth. 1989. Neutrophil activation by recombinant cytokines. Rev. Infect. Dis. 11:549-568.
10. Pober, J.S., M.A. Gimbrone, Jr., L.A. Lapierre, D.L. Mendrick, W. Fiers, R. Rothlein, and T.A. Springer. 1986. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J. Immunol. 137:1893-1896.
11. Doukas, J., and J.S. Pober. 1990. IFN-gamma enhances endothelial activation induced by tumor necrosis factor but not IL-1. J. Immunol. 145:1727-1733.
12. Issekutz, A.C., and N. Lopes. 1993. Endotoxin activation of endothelium for polymorphonuclear leukocyte transendothelial migration and modulation by interferon-gamma. Immunology. 79:600-607.
13. Ribeiro, R.A., F.Q. Cunha, and S.H. Ferreira. 1990. Recombinant gamma interferon causes neutrophil migration mediated by the release of a macrophage neutrophil chemotactic factor. Int. J. Exp. Pathol. 71:717-725.
14. Gerritsen, M.E., M.J. Niedbala, A. Szczepanski, and W.W. Carley. 1993. Cytokine activation of human macro- and microvessel-derived endothelial cells. Blood Cells. 19:325-339.
15. Meda, L., S. Gasperini, M. Ceska, and M.A. Cassatella. 1994. Modulation of proinflammatory cytokine release from human polymorphonuclear leukocytes by gamma interferon. Cell. Immunol. 157:448-461.
16. Leeuwenberg, J.F.M., E.J.U. Von Asmuth, T.M.A.A. Jeunhomme, and W.A. Buurman. 1990. Interferon-gamma regulates the expression of the adhesion molecule ELAM-1 and IL-6 production by human endothelial cells in vitro. J. Immunol. 145:2110-2114.
17. Hendricks, R.L., and J. Sugar. 1984. Lysis of herpes simplex virus-infected targets. II. Nature of the effector cells. Cell. Immunol. 83:262-270.
18. Lewinsohn, D.M., R.F. Bargatze, and E.C. Butcher. 1987. Leukocyte-endothelial cell recognition: evidence of a common molecular mechanism shared by neutrophils, lymphocytes, and other leukocytes. J. Immunol. 138:4313-4321.
19. Mulligan, M.S., G.P. Wilson, R.F. Todd, III, C.W. Smith, D.C. Anderson, J. Varani, T.B. Issekutz, M. Myasaka, T. Tamatani, J.R. Rusche et al. 1993. Role of β1, β2 integrins and ICAM-1 in lung injury after deposition of IgG and IgA immune complexes. J. Immunol. 150:2407-2417.
20. Barton, R.W., R. Rothlein, J. Ksiazek, and C. Kennedy. 1989. The effect of anti-intercellular adhesion molecule-1 on phorbol-ester-induced rabbit lung inflammation. J. Immunol. 143:1278-1282.
21. Mulligan, M.S., G.O. Till, C.W. Smith, D.C. Anderson, M. Miyasaka, T. Tamatani, R.F. Todd, III, T.B. Issekutz, and P.A. Ward. 1994. Role of leukocyte adhesion molecules in lung and dermal vacular injury after thermal trauma of skin. Am. J. Pathol. 144:1008-1015.
22. Yoshida, N., D.N. Granger, D.C. Anderson, R. Rothlein, C. Lane, and P.R. Kvietys. 1992. Anoxia/reoxygenation-induced neutrophil adherence to cultured endothelial cells. Am. J. Physiol. 262:H1891-H1898.
23. Muller, W.A., S.A. Weigl, X. Deng, and D.M. Phillips. 1993. PECAM-1 is required for transendothelial migration of leukocytes. J. Exp. Med. 178:449-460.
24. Bogen, S., J. Pak, M. Garifallou, X. Deng, and W. Muller. 1994. Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo. J. Exp. Med. 179:1059-1064.
25. Vaporciyan, A.A., H.M. DeLisser, H.C. Yan, I.I. Mendiguren, S.R. Thom, M.L. Jones, P.A. Ward, and S.M. Albelda. 1993. Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science (Wash. DC). 262:1580-1582.
26. Bogen, S.A., H.S. Baldwin, S.C. Watkins, S.M. Albelda, and A.K. Abbas. 1992. Association of murine CD31 with transmigrating lymphocytes following antigenic stimulation. Am. J. Pathol. 141:843-854.
27. Russell, R.G., M.P. Nasisse, H.S. Larsen, and B.T. Rouse. 1984. Role of T-lymphocytes in the pathogenesis of herpetic stromal keratitis. Invest. Opthalmol. Vis. Sci. 25:938-944.
28. Ksander, B.R., and R.L. Hendricks. 1987. Cell-mediated immune tolerance to HSV-1 antigens associated with reduced susceptibility to HSV-1 corneal lesions. Invest. Ophthalmol. Vis. Sci. 28:1986-1993.
29. Metcalf, J.F., D.S. Hamilton, and R.W. Reichert. 1979. Herpetic keratitis in athymic (nude) mice. Infect. Immun. 26: 1164-1171.
30. Metcalf, J.F., and H.E. Kaufman. 1976. Herpetic stromal keratitis: evidence for cell-mediated immunopathogenesis. Am. J. Ophthalmol. 82:827-834.
31. Hendricks, R.L., R.J. Epstein, and T.M. Tumpey. 1989. The effect of cellular immune tolerance to HSV-1 antigens on the immunopathology of HSV-1 keratitis. Invest. Ophthalmol. Vis. Sci. 30:105-115.
32. Hendricks, R.L., M.S.P. Tao, and J.C. Glorioso. 1989. Alterations in the antigenic structure of two major HSV-1 glycoproteins, gC and gB, influence immune regulation and susceptibility to murine herpes keratitis. J. Immunol. 142:263-269.
33. Newell, C.K., S. Martin, D. Sendele, C.M. Mercadal, and B.T. Rouse. 1989. Herpes simplex virus-induced stromal keratitis: role of T-lymphocyte subsets in immunopathology. J. Virol. 63:769-775
34. Hendricks, R.L., and T.M. Tumpey. 1991. Concurrent regeneration of T lymphocytes and susceptibility to HSV-1 corneal stromal disease. Curr. Eye Res. 10:47-53.
35. + T-lymphocyte depletion on the induction and expression of herpes simplex stromal keratitis. Reg. Immunol. 2:366-369.
36. + T lymphocytes. Invest. Ophthalmol. Vis. Sci. 33:2165-2173.
37. Thornhill, M.H., U. Kyan-Aung, T.H. Lee, and D.O. Haskard. 1990. T cells and neutrophils exhibit differential adhesion to cytokine-stimulated endothelial cells. Immunology. 69:287-292
38. Issekutz, T.B., J.M. Stoltz, and P. van der Meide. 1988. Lymphocyte recruitment in delayed-type hypersensitivity. The role of IFN-gamma. J. Immunol. 140:2989-2993.
39. Issekutz, A.C., and T.B. Issekutz. 1993. Quantitation and kinetics of blood monocyte migration to acute inflammatory reactions, and IL-1 alpha, tumor necrosis factor-alpha, and IFN-gamma. J. Immunol. 151:2105-2115.
40. Springer, T.A. 1990. Adhesion receptors of the immune system. Nature (Lond.). 346:425-434.
41. Renkonen, R., P. Mattila, M.-L. Majuri, T. Paavonen, and O. Silvennoinen. 1992. IL-4 decreases IFN-γ-gamma-induced endothelial ICAM-1 expression by a transcriptional mechanism. Scand. J. Immunol. 35:525-530.
42. Carlos, T.M., B.R. Schwartz, N.L. Kovach, E. Yee, M. Rosa, L. Osborn, G. Chi-Rosso, B. Newman, and R. Lobb. 1990. Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells. Blood. 76:965-970.
43. Dustin, M.L., R. Rothlein, A.K. Bhan, C.A. Dinarello, and T.A. Springer. 1986. Induction by IL-1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 137: 245-254.
44. Kurose, I., C. Pothoulakis, J.T. LaMont, D.C. Anderson, J.C. Pauson, M. Miyasaka, R. Wolf, and D.N. Granger. 1994. Clostridium difficile toxin A-induced microvascular dysfunction. Role of histamine. J. Clin. Invest. 94:1919-1926.
45. Wallace, J.L., W. McKnight, M. Miyasaka, T. Tamatani, J. Paulson, D.C. Anderson, D.N. Granger, and P. Kubes. 1993. Role of endothelial adhesion molecules in NSAID-induced gastric mucosal injury. Am. J. Physiol. 265:G993-G998.
46. Issekutz, A.C., and T.B. Issekutz. 1993. A major portion of polymorphonuclear leukocyte and T lymphocyte migration to arthritic joints in the rat is via LFA-1/MAC-1-independent mechanisms. Clin. Immunol. Immunopathol. 67:257-263.
47. Munro, J.M., J.S. Pober, and R.S. Cotran. 1991. Recruitment of neutrophils in the local endotoxin response: association with de novo endothelial expression of endothelial leukocyte adhesion molecule-1. Lab. Invest. 64:295-299.
48. Staats, H.F., and R.N. Lausch. 1993. Cytokine expression in vivo during murine herpetic stromal keratitis. J. Immunol. 151:277-283.
49. Favaloro, E.J. 1993. Differential expression of surface antigens on activated endothelium. Immunol. Cell Biol. 71:571-581.
50. Romer, L.H., N.V. McLean, H.-C. Yan, M. Daise, J. Sun, and H.M. DeLisser. 1995. IFN-γ and TNF-α induce redistribution of PECAM-1 (CD31) on human endothelial cells. J. Immunol. 154:6582-6592.
51. DeLisser, H.M., P.J. Newman, and S.M. Albelda. 1994. Molecular and functional aspects of PECAM-1/CD31. Immunol. Today. 15:490-495.
52. Berger, R., S.M. Albelda, D. Berd, M. Ioffreda, D. Whitaker, and G.F. Murphy. 1993. Expression of platelet-endothelial cell adhesion molecule-1 (PECAM-1) during melanoma-induced angiogenesis in vivo. J. Cutan. Pathol. 20:399-406.
53. Liao, F., H.K. Huynh, A. Eiroa, T. Greene, E. Polizzi, and W.A. Muller. 1995. Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1. J. Exp. Med. 182: 1337-1343.
54. Wakelin, M.W., M.-J. Sanz, A. Dewar, S.M. Albelda, S.W. Larkin, N. Boughton-Smith, T.J. Williams, and S. Nourshargh. 1996. An anti-platelet-endothelial cell adhesion molecule-1 antibody inhibits leukocyte extravasation from mesenteric microvessels in vivo by blocking the passage through the basement membrane. J. Exp. Med. 184:229-239.